219 related articles for article (PubMed ID: 19274700)
1. Breast cancer, estrogen receptor and ligands.
Bai Z; Gust R
Arch Pharm (Weinheim); 2009 Mar; 342(3):133-49. PubMed ID: 19274700
[TBL] [Abstract][Full Text] [Related]
2. The estrogen receptor: a model for molecular medicine.
Jensen EV; Jordan VC
Clin Cancer Res; 2003 Jun; 9(6):1980-9. PubMed ID: 12796359
[TBL] [Abstract][Full Text] [Related]
3. [Breast cancer].
Iwase H
Nihon Rinsho; 2006 Sep; Suppl 3():379-83. PubMed ID: 17022569
[No Abstract] [Full Text] [Related]
4. Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain.
Blizzard TA; DiNinno F; Chen HY; Kim S; Wu JY; Chan W; Birzin ET; Yang YT; Pai LY; Hayes EC; DaSilva CA; Rohrer SP; Schaeffer JM; Hammond ML
Bioorg Med Chem Lett; 2005 Sep; 15(17):3912-6. PubMed ID: 15993065
[TBL] [Abstract][Full Text] [Related]
5. Selective estrogen receptor modulators: an update on recent clinical findings.
Shelly W; Draper MW; Krishnan V; Wong M; Jaffe RB
Obstet Gynecol Surv; 2008 Mar; 63(3):163-81. PubMed ID: 18279543
[TBL] [Abstract][Full Text] [Related]
6. [Estrogen receptor subtypes and the regulatory effect of receptor ligand binding on gene transcription].
An SJ; Zhang YX
Sheng Li Ke Xue Jin Zhan; 2002 Oct; 33(4):309-12. PubMed ID: 12650065
[TBL] [Abstract][Full Text] [Related]
7. [Selective estrogen receptor modulators: mechanisms of action and their tissue selectivity].
Azuma K; Inoue S
Clin Calcium; 2004 Oct; 14(10):12-26. PubMed ID: 15577127
[TBL] [Abstract][Full Text] [Related]
8. The molecular determinants of estrogen receptor pharmacology.
McDonnell DP
Maturitas; 2004 Aug; 48 Suppl 1():S7-12. PubMed ID: 15337242
[TBL] [Abstract][Full Text] [Related]
9. [Estrogen receptors and breast cancer].
Maudelonde T; Pujol P; Rochefort H
Rev Prat; 1994 May; 44(10):1299-303. PubMed ID: 7939188
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor and breast cancer.
Sommer S; Fuqua SA
Semin Cancer Biol; 2001 Oct; 11(5):339-52. PubMed ID: 11562176
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen receptors and selective oestrogen receptor modulators: molecular and cellular pharmacology.
Nilsson S; Koehler KF
Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):15-25. PubMed ID: 15667591
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in estrogen receptor modulators.
Henke BR; Heyer D
Curr Opin Drug Discov Devel; 2005 Jul; 8(4):437-48. PubMed ID: 16022180
[TBL] [Abstract][Full Text] [Related]
13. Advantages of multiple clinical tests for determining the optimum treatment strategy for ER-positive breast cancer.
Ditzel HJ; Lyng MB
Nat Clin Pract Oncol; 2008 Jul; 5(7):376-7. PubMed ID: 18506164
[No Abstract] [Full Text] [Related]
14. The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer.
Spears M; Bartlett J
Expert Opin Ther Targets; 2009 Jun; 13(6):665-74. PubMed ID: 19456271
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology and clinical use of sex steroid hormone receptor modulators.
Cleve A; Fritzemeier KH; Haendler B; Heinrich N; Möller C; Schwede W; Wintermantel T
Handb Exp Pharmacol; 2012; (214):543-87. PubMed ID: 23027466
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanism of tissue-specific actions of SERM].
Kato S
Clin Calcium; 2006 Sep; 16(9):1469-74. PubMed ID: 16951470
[TBL] [Abstract][Full Text] [Related]
17. A pharmacophore-based evolutionary approach for screening selective estrogen receptor modulators.
Yang JM; Shen TW
Proteins; 2005 May; 59(2):205-20. PubMed ID: 15726586
[TBL] [Abstract][Full Text] [Related]
18. [The molecular mechanisms of estrogens. Clinical aspects, industrial estrogens and phytoestrogens].
Hagen ML; Hellmers M; Abrahamsen B; Hagen C
Ugeskr Laeger; 2004 Mar; 166(13):1220-4. PubMed ID: 15088482
[No Abstract] [Full Text] [Related]
19. Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer.
McCafferty MP; McNeill RE; Miller N; Kerin MJ
Breast Cancer Res Treat; 2009 Aug; 116(3):425-32. PubMed ID: 19507020
[TBL] [Abstract][Full Text] [Related]
20. The molecular pharmacology of estrogen receptor modulators: implications for the treatment of breast cancer.
McDonnell DP
Clin Cancer Res; 2005 Jan; 11(2 Pt 2):871s-7s. PubMed ID: 15701880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
